StreetInsider.com News Articles

RedChip's Future Tech Investor Conference Replays Now Available

Wed, 17 Jun 2026 09:00:00 -0400

ORLANDO, FL / ACCESS Newswire / June 17, 2026 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced that on-demand replays from its Future Tech: Profiting from Technologies Transforming Work, Life, and Industry investor conference, held June 10, 2026, are now available.

The full-day virtual event featured senior executives from publicly traded companies developing and commercializing technologies that are reshaping industries and redefining how people work, live, and interact. The conference highlighted innovation across artificial intelligence, automation, advanced computing, digital infrastructure, software platforms,

RedChip's Future Tech Investor Conference Replays Now Available

Wed, 17 Jun 2026 09:00:00 -0400

RedChip's Future Tech Investor Conference Replays Now Available

Wed, 17 Jun 2026 09:00:00 -0400

RedChip's Future Tech Investor Conference Replays Now Available

Wed, 17 Jun 2026 09:00:00 -0400

RedChip's Future Tech Investor Conference Replays Now Available

Wed, 17 Jun 2026 09:00:00 -0400

RedChip's Future Tech Investor Conference Replays Now Available

Wed, 17 Jun 2026 09:00:00 -0400

Ainos launches NTU breath-analysis research program for ER dyspnea

Wed, 17 Jun 2026 08:01:36 -0400

Ainos, Inc. (NASDAQ: AIMD, NASDAQ: AIMDW) has announced a one-year research program with National Taiwan University to study the use of its Smell AI platform in emergency medicine, according to a company press release.

The program, titled "Rapid Diagnosis of Dyspneic Patients in the Emergency Department via AI-powered Electronic Nose Technology," is scheduled to run from July 1, 2026. It will examine whether AI-driven analysis of volatile organic compounds in exhaled breath can help emergency physicians evaluate patients presenting with dyspnea, or shortness of breath.

The research aims to develop a system called Deep Dyspnea Differential, which would analyze VOC-based breath patterns

Ainos launches NTU breath-analysis research program for ER dyspnea

Wed, 17 Jun 2026 08:01:36 -0400

The research aims to develop a system called Deep Dyspnea Differential, which would analyze VOC-based breath patterns

Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program

Wed, 17 Jun 2026 08:00:00 -0400

Program expands Ainos' Smell AI platform from environmental intelligence into digital breath intelligence for emergency medicine research

HOUSTON, TX / ACCESS Newswire / June 17, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent digitization and Smell AI technologies, today announced a new research program with National Taiwan University ("NTU") to explore the use of Smell AI in emergency medicine.

The program, titled "Rapid Diagnosis of Dyspneic Patients in the Emergency Department via AI-powered Electronic Nose Technology," will explore the use of Ainos' Smell AI platform to analyze

Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program

Wed, 17 Jun 2026 08:00:00 -0400

Program expands Ainos' Smell AI platform from environmental intelligence into digital breath intelligence for emergency medicine research

The program, titled "Rapid Diagnosis of Dyspneic Patients in the Emergency Department via AI-powered Electronic Nose Technology," will explore the use of Ainos' Smell AI platform to analyze

Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program

Wed, 17 Jun 2026 08:00:00 -0400

Program expands Ainos' Smell AI platform from environmental intelligence into digital breath intelligence for emergency medicine research

The program, titled "Rapid Diagnosis of Dyspneic Patients in the Emergency Department via AI-powered Electronic Nose Technology," will explore the use of Ainos' Smell AI platform to analyze

Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program

Wed, 17 Jun 2026 08:00:00 -0400

Program expands Ainos' Smell AI platform from environmental intelligence into digital breath intelligence for emergency medicine research

The program, titled "Rapid Diagnosis of Dyspneic Patients in the Emergency Department via AI-powered Electronic Nose Technology," will explore the use of Ainos' Smell AI platform to analyze

Form 4 Ainos, Inc. For: Jun 05 Filed by: chiang yao-chung

Tue, 09 Jun 2026 12:05:00 -0400

si-local-file:///var/storage/secattach/20260609/26622583.html

Form 4 Ainos, Inc. For: Jun 05 Filed by: chiang yao-chung

Tue, 09 Jun 2026 12:05:00 -0400

si-local-file:///var/storage/secattach/20260609/26622583.html

Ainos reports 499% revenue growth in 2025, expands AI scent technology

Mon, 08 Jun 2026 08:00:11 -0400

Ainos Inc. (NASDAQ: AIMD) released its 2026 mid-year shareholder letter, reporting 499% year-over-year revenue growth during fiscal year 2025. The company has shifted from biotechnology focus to technology platform development centered on artificial intelligence-powered scent digitization.

The Houston-based company advanced commercial deployments in semiconductor manufacturing environments during the first half of 2026. Ainos collaborated with advanced semiconductor manufacturers and strategic industry partners to expand industrial-scale scent AI datasets for environmental intelligence and safety monitoring applications.

The company expanded its scent AI technology into healthcare settings through collaborative research programs with National Taiwan University Hospital and MacKay Memorial Hospital. These initiatives focus on

Ainos reports 499% revenue growth in 2025, expands AI scent technology

Mon, 08 Jun 2026 08:00:11 -0400

Ainos Releases 2026 Mid-Year CEO Letter to Shareholders

Mon, 08 Jun 2026 08:00:00 -0400

Building the Olfactory Layer of Physical AI

Highlighting Progress Across Semiconductor Manufacturing, Healthcare Infrastructure and Physical AI Applications

HOUSTON, TX / ACCESS Newswire / June 8, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent digitization and Smell AI technologies, today released its 2026 Mid-Year Letter to Shareholders from Chairman, President and Chief Executive Officer Eddy Tsai.

2026 First Half Highlights

Commercial Momentum

Reported 499% year-over-year revenue growth during fiscal year 2025.
Continued transforming Ainos from a biotechnology-focused company into a technology platform company centered on Smell AI and Environmental Intelligence.
Updated the

Ainos Releases 2026 Mid-Year CEO Letter to Shareholders

Mon, 08 Jun 2026 08:00:00 -0400

Building the Olfactory Layer of Physical AI

Highlighting Progress Across Semiconductor Manufacturing, Healthcare Infrastructure and Physical AI Applications

2026 First Half Highlights

Commercial Momentum

Reported 499% year-over-year revenue growth during fiscal year 2025.
Continued transforming Ainos from a biotechnology-focused company into a technology platform company centered on Smell AI and Environmental Intelligence.
Updated the

Ainos Releases 2026 Mid-Year CEO Letter to Shareholders

Mon, 08 Jun 2026 08:00:00 -0400

Building the Olfactory Layer of Physical AI

Highlighting Progress Across Semiconductor Manufacturing, Healthcare Infrastructure and Physical AI Applications

2026 First Half Highlights

Commercial Momentum

Reported 499% year-over-year revenue growth during fiscal year 2025.
Continued transforming Ainos from a biotechnology-focused company into a technology platform company centered on Smell AI and Environmental Intelligence.
Updated the

Ainos Releases 2026 Mid-Year CEO Letter to Shareholders

Mon, 08 Jun 2026 08:00:00 -0400

Building the Olfactory Layer of Physical AI

Highlighting Progress Across Semiconductor Manufacturing, Healthcare Infrastructure and Physical AI Applications

2026 First Half Highlights

Commercial Momentum

Reported 499% year-over-year revenue growth during fiscal year 2025.
Continued transforming Ainos from a biotechnology-focused company into a technology platform company centered on Smell AI and Environmental Intelligence.
Updated the

Form 4 Ainos, Inc. For: Jun 03 Filed by: chiang yao-chung

Fri, 05 Jun 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260605/26611120.html

Form 4 Ainos, Inc. For: Jun 03 Filed by: chiang yao-chung

Fri, 05 Jun 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260605/26611120.html

Ainos expands AI Nose platform into hospital emergency departments

Fri, 05 Jun 2026 08:02:52 -0400

Ainos Inc. (NASDAQ: AIMD) announced that research firm VASRO GmbH published a report discussing the company's expansion of its AI Nose platform into emergency department operations at an Asian academic medical center.

The research program deploys AI Nose technology within a live emergency department to evaluate environmental scent analysis for overcrowding early warning and respiratory infection risk analysis. The initiative is designed to generate more than 2,500 hours of emergency department environmental data.

According to the VASRO report, this deployment expands AI Nose beyond its current applications in semiconductor manufacturing, industrial environments, and robotics into healthcare infrastructure. The platform digitizes scent into

Ainos expands AI Nose platform into hospital emergency departments

Fri, 05 Jun 2026 08:02:52 -0400

VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations

Fri, 05 Jun 2026 08:00:00 -0400

HOUSTON, TX / ACCESS Newswire / June 5, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a Smell AI company digitizing scent into machine-readable data for artificial intelligence applications, today highlighted a recent report published by VASRO GmbH ("VASRO"), discussing the expansion of the Company's AI Nose platform into emergency department operations and the continued growth of its Smell ID data across diverse real-world environments.

In the report, VASRO reviews Ainos' recently announced research program at one of Asia's leading academic medical centers, where AI Nose is being deployed within a live